Skip to main content

Advertisement

Log in

Epidemiology of acute liver failure

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Acute liver failure (ALF) is an uncommon disorder that leads to jaundice, coagulopathy, and multisystem organ failure. Its definition is based on the timing from onset of jaundice to encephalopathy. In 2005, ALF accounted for 6% of liver-related deaths and 7% of orthotopic liver transplants (OLT) in the United States. Several classification systems have been developed for ALF, with the King’s College criteria most widely used for prediction of OLT. Specific diagnostic tests should be implemented to identify the cause of ALF, which will help to determine its treatment and prognosis. Viral hepatitis was previously reported to be the most common cause of ALF in the United States, but acetaminophen overdose and idiosyncratic drug reactions have emerged as the most frequent causes in recent studies. Malignancy is an uncommon cause of ALF, and thus imaging studies may not be useful in this setting, but liver biopsy may be beneficial in selected cases. An overall strategy for ALF should start with identifying the cause, assessing the prognosis, and early transfer to a transplantation center for suitable candidates. OLT has emerged as a life-saving procedure leading to marked improvement in survival rates. Improved surgical techniques, immunosuppression, and comprehensive care have led to an overall survival rate of approximately 65% with OLT. N-acetylcysteine is effective in ALF caused by acetaminophen overdose, with results strongly related to how soon it is given rather than the route of administration. Liver support systems show potential for the treatment of ALF, but their role needs validation in large multicenter randomized trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Rakela J, Lange SM, Ludwig J, Baldus WP: Fulminant hepatitis: Mayo Clinic experience with 34 cases. Mayo Clin Proc 1985, 60:289–292.

    PubMed  CAS  Google Scholar 

  2. Ostapowicz G, Fontana RJ, Schiodt FV, et al.: Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002, 137:947–954.

    PubMed  Google Scholar 

  3. Hoofnagle JH, Carithers RLJ, Shapiro C, Ascher N: Fulminant hepatic failure: summary of a workshop. Hepatology 1995, 21:240–252.

    PubMed  CAS  Google Scholar 

  4. Sakaida I, Kimura T, Yamasaki T, et al.: Cytochrome c is a possible new marker for fulminant hepatitis in humans. J Gastroenterol 2005, 40:179–185.

    Article  PubMed  CAS  Google Scholar 

  5. Hiraoka A, Horiike N, Akbar SM, et al.: Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure. J Gastroenterol 2005, 40:52–56.

    Article  PubMed  CAS  Google Scholar 

  6. Miyake Y, Sakaguchi K, Iwasaki Y, et al.: New prognostic scoring model for liver transplantation in patients with non-acetaminophen-related fulminant hepatic failure. Transplantation 2005, 80:930–936.

    Article  PubMed  Google Scholar 

  7. Arai M, Yokosuka O, Kanda T, et al.: Serum osteopontin levels in patients with acute liver dysfunction. Scand J Gastroenterol 2006, 41:102–110.

    Article  PubMed  CAS  Google Scholar 

  8. Bernal B: Changing patterns of causation and the use of transplantation in the United Kingdom. Semin Liver Dis 2003, 23:227–237.

    Article  PubMed  Google Scholar 

  9. Polard E, Camus C, Abault AY, et al.: Retransplantation for acute liver failure due to combined antiviral agents in an HIV-HCV coinfected liver transplant recipient. Transplantaton 2005, 80:1136–1138.

    Article  Google Scholar 

  10. Lewis W, Day BJ, Copeland WC: Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev Drug Discov 2003, 2:812–822.

    Article  PubMed  CAS  Google Scholar 

  11. Lafeuillade A, Hittinger G, Chapadaud S: Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection. Lancet 2001, 357:280.

    Article  PubMed  CAS  Google Scholar 

  12. Qazilbash MH, Qu Z, Hosing C, et al.: Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia. Am J Hematol 2005, 80:43–45.

    Article  PubMed  Google Scholar 

  13. Cross TJ, Bagot C, Portmann B, et al.: Imatinib mesylate as a cause of acute liver failure. Am J Hematol 2006, 81:189–192.

    Article  PubMed  Google Scholar 

  14. Clay KD, Hanson JS, Pope SD, et al.: Brief communication: severe hepatotoxicity of telithromycin: three case reports and literature review. Ann Intern Med 2006, 144:142

    Google Scholar 

  15. Hanje AJ, Pell LJ, Votolato NA, et al.: Case report: Fulminant hepatic failure involving duloxetine hydrochloride. Clinical Gastroenterol Hepatol 2006, 4:912–917.

    Article  Google Scholar 

  16. Thurairajah PH, Syn WK, Neil DA, et al.: Orlistat (Xenical)-induced subacute liver failure. Eur J Gastroenterol Hepatol 2005, 17:1437–1438.

    Article  PubMed  Google Scholar 

  17. Yeo W, Johnson PJ: Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology 2006, 43:209–220.

    Article  PubMed  CAS  Google Scholar 

  18. Montalbano M, Slapak-Green GI, Neff GW: Fulminant hepatic failure from herpes simplex virus: post liver transplantation acyclovir therapy and literature review. Transplant Proc 2005, 37:4393–4396.

    Article  PubMed  CAS  Google Scholar 

  19. Ichai P, Afonso IS, Sebagh M, et al.: Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis. Liver Transpl 2005, 11:1550–1555.

    Article  PubMed  Google Scholar 

  20. Mantadakis E, Anagnostatou N, Danilatou V, et al.: Fulminant hepatitis due to varicella zoster virus in a girl with acute lymphoblastic leukemia in remission: report of a case and review. J Pediatr Hematol Oncol 2005, 27:551–553.

    Article  PubMed  Google Scholar 

  21. Cacheux W, Carbonell N, Rosmorduc O, et al.: HHV-6-related acute liver failure in two immunocompetent adults: favourable outcome after liver transplantation and/or ganciclovir therapy. J Intern Med 2005, 258:573–578.

    PubMed  CAS  Google Scholar 

  22. Dutta U, Mittal S, Ratho RK, Das A: Acute liver failure and severe hemophagocytosis secondary to parvovirus B19 infection. Indian J Gastroenterol 2005, 24:118–119.

    PubMed  Google Scholar 

  23. Devarbhavi H, Alvares JF, Kumar KS: Severe falciparum malaria simulating fulminant hepatic failure. Mayo Clin Proc 2005, 80:355–358.

    Article  PubMed  Google Scholar 

  24. Tillmann HL, Hadem J, Leifeld L, et al.: Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat 2006, 13:256–263.

    Article  PubMed  CAS  Google Scholar 

  25. Harrison HM, Crosby J Jr: Fulminant hepatic failure: an unusual presentation of metastatic liver disease. Gastroenterology 1981, 80:820–825.

    PubMed  CAS  Google Scholar 

  26. Nakagawa K, Miller FN, Sims DE, et al.: Mechanisms of interleukin-2-induced hepatic toxicity. Cancer Res 1996, 56:507–510.

    PubMed  CAS  Google Scholar 

  27. McElreath DP, Angtuaco TL, Staggs B, Malik AH: T cell prolymphocytic leukemia: a rare cause of acute liver failure. Dig Dis Sci 2006, 51:819–821.

    Article  PubMed  Google Scholar 

  28. Boyiadzis M, Nam M, Dahut W: Fulminant hepatic failure secondary to metastatic prostate cancer. Urol Int 2005, 74:185–187.

    Article  PubMed  Google Scholar 

  29. Kaplan GG, Medllicott S, Culleton B, Laupland KB: Acute hepatic failure and multi-system organ failure secondary to replacement of the liver with metastatic melanoma. BMC Cancer 2005, 5:67.

    Article  PubMed  Google Scholar 

  30. Rajvanshi P, Kowdley KV, Hirota WK, et al.: Fulminant hepatic failure secondary to neoplastic infiltration of the liver. J Clin Gastroenterol 2005, 39:339–343.

    Article  PubMed  Google Scholar 

  31. Cameron AM, Truty J, Truell J, et al.: Fulminant hepatic failure from primary hepatic lymphoma: successful treatment with orthotopic liver transplantation and chemotherapy. Transplantation 2005, 80:993–996.

    Article  PubMed  Google Scholar 

  32. Fussell KM, Awad JA, Ware LB: Case of fulminant hepatic failure due to unrecognized peripartum cardiomyopathy. Crit Care Med 2005, 33:891–893.

    Article  PubMed  Google Scholar 

  33. Abujudeh H, Contractor D, Delatorre A, Koneru B: Rescue TIPS in acute Budd-Chiari syndrome. Am J Roentgenol AJR 2005, 185:89–91.

    Google Scholar 

  34. Ganger DR, Klapman JB, McDonald V, et al.: Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. Am J Gastroenterol 1999, 94:603–608.

    PubMed  CAS  Google Scholar 

  35. Verhoeven NM, Wallot M, Huck JH, et al.: A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency. J Inher Metabol Dis 2005, 28:169–179.

    Article  CAS  Google Scholar 

  36. Fiedler A, Wichers-Rother M, Hoeft A, et al.: Schmidt syndrome presenting as acute liver failure. Exp Clin Endocrinol Diabetes 2005, 113:60–63.

    Article  PubMed  CAS  Google Scholar 

  37. Kessler WR, Cummings OW, Eckert G, et al.: Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2004, 2:625–631.

    Article  PubMed  Google Scholar 

  38. Buckley NA, Whyte IM, O’Connell DL, Dawson AH: Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning? Clin Toxicol 1999, 37:759–767.

    Article  CAS  Google Scholar 

  39. Kearney TE: Acetylcysteine. In Poisoning and Drug Overdose. Edited by Olson KR. New York: Lange Medical Books/McGraw-Hill; 2004:405–407.

    Google Scholar 

  40. Ascher NL, Lake JR, Emond JC, Roberts JP: Liver transplantation for fulminant hepatic failure. Arch Surg 1993, 128:677–682.

    PubMed  CAS  Google Scholar 

  41. Montalti R, Nardo B, Beltempo P, et al.: Liver transplantation in fulminant hepatic failure: experience with 40 adult patients over a 17-year period. Transplant Proc 2005, 37:1085–1087.

    Article  PubMed  CAS  Google Scholar 

  42. Pinelli D, Spada M, Lucianetti A, et al.: Transplantation for acute liver failure in children. Transplant Proc 2005, 37:1146–1148.

    Article  PubMed  CAS  Google Scholar 

  43. Nyckowski P, Skwarek A, Zieniewicz K, et al.: Orthotopic liver transplantation for fulminant hepatic failure. Transplant Proc 2006, 38:219–220.

    Article  PubMed  CAS  Google Scholar 

  44. Tissieres P, Sasbon JS, Devictor D: Liver support for fulminant hepatic failure: is it time to use the molecular adsorbents recycling system in children? Pediatr Crit Care Med 2005, 6:585–591.

    Article  PubMed  Google Scholar 

  45. Lee KH, Lee MK, Sutedja DS, Lim SG: Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure. Liver Int 2005, 25:973–977.

    Article  PubMed  CAS  Google Scholar 

  46. Sein Anand J, Chodorowsk Z, Hydzik P: Molecular adsorbent recirculating system: MARS as a bridge to liver transplantation in amanita phalloides intoxication. Przeglad Lekarski 2005, 62:480–481.

    PubMed  Google Scholar 

  47. Doria C, Mandala L, Scott VL, et al.: Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: a single-center experience. Dig Dis Sci 2006, 51:47–53.

    Article  PubMed  CAS  Google Scholar 

  48. Tsai MH, Chen YC, Wu CS, et al.: Extracorporal liver support with molecular adsorbents recirculating system in patients with hepatitis B-associated fulminant hepatic failure. Int J Clin Pract 2005, 59:1289–1294.

    Article  PubMed  Google Scholar 

  49. Du WB, Li LJ, Huang JR, et al.: Effects of artificial liver support system on patients with acute or chronic liver failure. Transplant Proc 2005, 37:4359–4364.

    Article  PubMed  CAS  Google Scholar 

  50. Inderbitzin D, Muggli B, Ringger A, et al.: Molecular absorbent recirculating system for the treatment of acute liver failure in surgical patients. J Gastrointest Surg 2005, 9:1155–1161.

    Article  PubMed  Google Scholar 

  51. O’Grady JG, Alexander GJ, Hayllar KM, Williams R: Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989, 97:439–445.

    PubMed  CAS  Google Scholar 

  52. O’Grady JG: Acute liver failure. Postgrad Med J 2005, 81:148–154.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul Y. Kwo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khashab, M., Tector, A.J. & Kwo, P.Y. Epidemiology of acute liver failure. Curr Gastroenterol Rep 9, 66–73 (2007). https://doi.org/10.1007/s11894-008-0023-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-008-0023-x

Keywords

Navigation